Persistence Market Research Blog

Hepatitis B virus (HBV) is disease related to the liver. Hepatitis B virus (HBV) infection results in deaths due to liver cancer and liver failure. The hepatitis B vaccine is available for all age groups to prevent HBV infection. The disease is caused due to transmission of Hepatitis B virus (HBV) through contact with body fluids, blood and semen of an infected person. Hepatitis B disease can cause acute and later may turn to chronic disease if not treated at early stage. In 2015, WHO estimated that 240 Mn people are infected with chronic hepatitis B virus. Every year more than 780,000 deaths occur due to complexity of hepatitis B viral infection. This infection caused by chronic hepatitis B virus develops fulminant hepatitis B (autoimmune disorder), liver cirrhosis, hepatocellular carcinoma (liver cancer), liver failure which can be treated by a liver transplant. The Global Alliance for Vaccines and Immunization (GAVI) provides direction and support to prevent transmission through vaccination. However, there is a significant decrease in incidence of hepatitis B virus infection after introduction of hepatitis B vaccine.

Interested in report: Please follow the below links to meet your requirements; Request for the Report Sample: http://www.persistencemarketresearch.com/samples/10571 Read the rest of this entry »

Oligoastrocytomas is a part of a group of brain tumor called “gliomas”. Glioma tumor is originated in the brain or spine. Oligoastrocytomas contains both astrocytoma cells and oligodendroglioma. About 2.3% of the brain tumors reported are diagnosed as oligoastrocytomas. Oligoastrocytomas is divided into two parts, low grade and anaplastic. According to the WHO grading system, anaplastic oligoastrocytomas are usually identify as grade 1 and grade 2 but sometimes they appear to be grade 4.  Anaplastic oligoastrocytomas can be characterized by high cellularity, conspicuous cytologic atypism, microvascular proliferation, mitotic activity and necrosis.  Patients suffering from this condition show symptoms like headache, seizure and speech or motor changes. According to the American Brain Cancer Association, clinical trials for the treatment of this tumor are in process to minimize the recurrence rate of anaplastic oligoastocytoma caused after the surgical removal of tumor or chemotherapy and radiation therapy session.

Interested in report: Please follow the below links to meet your requirements; Request for the Report Sample: http://www.persistencemarketresearch.com/samples/10502

Anaplastic oligoastrocytomas market is offers potential opportunities to cancer care industry.  Factors contributing the growth of anaplastic oligoastrocytomas market are rising geriatric population, increasing incidence of anaplastic oligoastrocytomas and increasing pace of clinical trials for novel drug development. Moreover factors such as advancement in technology and innovations in diangositc techniques is expected to drive the growth of anaplastic oligoastrocytoma market over the forecast period. However, lack of specific treatment and critical diagnosis of anaplastic oligoastrocytoma is the major challenge for anaplastic oligoastrocytomas market.

Basically the treatment of anaplastic oligoastrocytoma depends on the size of the tumor. The treatment is processed by surgery to remove the tumor. In order to eliminate the cancerous cells, the combinational therapies such as chemotherapy or radiation therapy are used as effective treatment for anaplastic oligoastrocytoma.

Anaplastic oligoastrocytoma market is segmented on basis of treatment Type, end user and region:

  • By Treatment Type
    • Chemotherapy
    • Radiation
  • By End Use
    • Hospitals
    • Cancer Centers
    • Surgical Centers

Oligoastrocytomas is most common in adults and generally occurs at the age of 35–50. Generally these type of tumors are found in both the genders. Children of age 0-14 are often diagnosed with oligoastrocytomas and these tumors comprises of only three percent of primary brain tumors.  Factors such as increasing demand for treatment therapies for anaplastic oligoastrocytoma, increasing prevalence of anaplastic oligoastrocytoma in emerging economies are expected provide traction to the growth of anaplastic oligoastrocytoma over the forecast period (2016-2026)

On the basis of region presence, anaplastic oligoastrocytoma market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North America and Europe market are at maturity level for clinical research of treatment for anaplastic oligoastrocytomas. Markets of Asia-Pacific region have also shown keen interest in clinical trials of this tumor and are showing growth at faster pace, due to increasing incidence of anaplastic oligoastrocytoma.

Request TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/10502

Following are the companies and institutions which are involved in clinical trials of treatment for anaplastic oligoastocytomas are Tocagen, Inc., Shandong Lanjin Pharmaceuticals Co. Ltd, Keryx Biopharmaceuticals, Inc., Biogen Idec, Inc., Insys Therapeutics, Inc, Rush University Medical Center and University of California, San Diego.

The report covers exhaustive analysis on:

  • Anaplastic Oligoastrocytoma Market Segments
  • Anaplastic Oligoastrocytoma Market Dynamics
  • Historical Actual Market Size, 2013 – 2015
  • Anaplastic Oligoastrocytoma Market Size & Forecast 2016 to 2022
  • Anaplastic Oligoastrocytoma Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Anaplastic Oligoastrocytoma Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Incontinence or Incontinent may refer to the involuntary excretion of bowel contents or urine. Difficulties with using the toilet, accidents and incontinence, can all be problems for people with dementia, particularly as the condition progresses. According to a report published by WHO, 5% to 7% of the world’s population is suffering from incontinence.  These problems can be upsetting for people and for those around them. Today a variety of products are available in the market, which can provide practical solutions to those people suffering from such ailments. Some of these are Protective Underwear & Briefs, Pads & Liners, Overnight diapers, Tab Style Diapers, skin care products to name a few.

Interested in report: Please follow the below links to meet your requirements; Request for the Report Sample: http://www.persistencemarketresearch.com/samples/8935

Incontinence products are a part of personal care segment, which is growing at a faster pace. This is due to the rise in aging population, increasing awareness and acceptance of incontinence products. Product innovations to customize the  products is also driving the incontinence care industry. The WHO report projects that in almost every country the proportion of people aged over 60 years is growing faster than any other age group, as a result of both longer life expectancy and declining fertility rates. Also the rise in the population of diabetic Mellitus patients worldwide provides a good platform for this market.  However, there are some bigger challenges faced by this industry like the threat of alternates and substitutes and the threat from low-cost manufacturers.

The incontinence products market can be segmented based on product type, into, external & internal. External products include; absorbent products, hand wash, gloves, body wash, barrier cream, repair cream,   hand held urinals, bed pads, shampoo caps,  whereas, internal products include; tampons, disposable urethral Inserts, pessaries. Based on raw material used- plastic, cotton fabric, super absorbents, cotton fiber, latex, others (water proof materials).

In terms distributional channel, the market is segmented into institutional & homecare and retail trade. Out of which institutional & homecare is estimated to be the major end-users, accounting approximately 60% of the global market for incontinence products and the retail market owns remaining 40% of the market.

Geographically, the incontinence products market is segmented into seven regions which are ; North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific Excluding Japan (APEJ), and Middle East and Africa (MEA) and Japan. Among all the regions, Western Europe is the highest contributor in term of revenue in global incontinence products market followed by Asia Pacific, North America & it is expected that in near future, Asia Pacific is going to lead this market.

Japan, having the highest proportion of elderly citizens could be a big market for this segment. The ever growing population of China will drive the demand for healthcare products, consequently resulting in the growth of the incontinence market in country. Saudi Arab, Kiribati, Kuwait, Bahrain are world’s leading diabetic prevalent nation. These countries also have a good market potential for incontinence products.

Some of the key players across the value chain dominating this market are Svenska Cellulosa Aktiebolaget SCA, Unicharm Corporation, HARTMANN GROUP, ONTEX International N.V., Hypermarcas SA, Kimberly-Clark Corporation, First Quality Enterprises Inc., Pro Descart Industria e Comercio Ltd, Coloplast A/S, C. R. Bard Inc., B. Braun Melsungen AG, Covidien plc and Medline Industries Inc, etc.

Request TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/8935

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, types, and applications.

The report covers exhaustive analysis on:

  • Incontinence Products Market Segments
  • Incontinence Products Market Dynamics
  • Historical Actual Market Size, 2013 – 2015
  • Incontinence Products Market Size & Forecast 2016 to 2026
  • Supply & Demand Value Chain
  • Incontinence Products Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain
  • Incontinence Products Market Drivers and Restraints

Regional analysis for incontinence products market includes

  • North America
    • US & Canada
  • Latin America
    • Brazil, Argentina & Others
  • Western Europe
    • EU5
    • Nordics
    • Benelux
  • Eastern Europe
  • Asia Pacific Except Japan
    • Australia and New Zealand (ANZ)
    • Greater China
    • India
    • ASEAN
    • Rest of Asia Pacific
  • Japan
  • The Middle East and Africa
    • GCC Countries
    • Other the Middle East
    • North Africa
    • South Africa
    • Other Africa

The report is a compilation of first-hand information, qualitative, and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics of the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance
  • Must-have information for market players to sustain and enhance their market footprint

Browse Full PDF: Incontinence Products Market

Cloud infrastructure manage tools includes software and technologies designed for operating and monitoring applications, data and services offered through the cloud. Cloud infrastructure manage tools assist cloud computing service providers to check cloud computing based resources are working efficiently and smoothly, interacting with users and other services. Cloud infrastructure manage tools performs numerous tasks including performance monitoring, security and compliance reviewing, and supervise the disaster recovery plans. The adoption of cloud computing services is growing day-by-day with the demand for private, public, and hybrid cloud. As traditional IT management tools are not sufficient to manage all these cloud models, this industry strongly witnesses need for cloud infrastructure manage tools.

Interested in report: Please follow the below links to meet your requirements; Request for the Report Sample: http://www.persistencemarketresearch.com/samples/10499

Cloud Infrastructure Manage Tools are used for one of the following service models of cloud computing

  • Software-as-a-Service (SaaS)
  • Platform-as-a-Service (PaaS)
  • Infrastructure-as-a-Service (IaaS)

Increasing demand for agility, scalability and cost effective solution is driving market for cloud computing services and in turn propelling the growth of the global infrastructure manage tools market. Cloud computing is creating new shift in IT model. Cloud computing facilitates organizations towards adopting IT as a service. IT as a service provide business organization a more agile framework and increase their efficiency, at the same time, IT as a service is a complex phenomenon and requires continuous monitoring. Cloud infrastructure manage tools provide continuous monitoring of this complex IT as a service environment.

However, business organizations’ technological needs are changing very frequently, and to cope with these rapidly changing technological advancements is quite tedious for cloud infrastructure manage tools.

Cloud Infrastructure manage tools market on the basis of cloud type:

  • Public Cloud :

Public cloud services are accessible for any organization. In this service model, service provider provide access to all computing need such as storage, server, and networking for any organization. Public cloud services may be free or offered pay-per-use model.

  • Private Cloud :

Companies that have very critical data which is susceptible to security related threat generally have their own cloud, in order to protect their data from external threat.

  • Hybrid Cloud :

Hybrid cloud is combination of public as well as private cloud and is used to perform distinct functions within the same organizations.  Number of vendors such as VMware and HP have designed cloud infrastructure manage tools. Each tool uses a variety of methods to warn of impeding problems or send a red flag when certain problem occurs.

North America is the largest market of cloud computing, hence poses huge opportunity for developer of cloud infrastructure manage tools.. Most of the developers of cloud infrastructure manage tools such as IBM Corporation, Microsoft Corporation are also headquartered in the U.S. and have large network of channel partners.

European Cloud Computing Strategy (ECCS) is an Initiative established by the European Commission in Europe to promote the adoption of cloud computing services is likely to boost cloud infrastructure manage tools market.

For more info: http://www.persistencemarketresearch.com/contact-us.asp

VMware, Inc., IBM Corporation, Microsoft Corporation, Cisco Systems, and CA Technologies are few of the leading players of global cloud infrastructure manage tools market.

The report covers exhaustive analysis on:

  • Cloud Infrastructure Manage Tools Market Segments
  • Cloud Infrastructure Manage Tools Market Dynamics
  • Historical Actual Market Size, 2013 – 2015
  • Cloud Infrastructure Manage Tools Market Size & Forecast 2016 to 2024
  • Cloud Infrastructure Manage Tools Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Cloud Infrastructure Manage Tools Market Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Browse Full PDF: Cloud Infrastructure Manage Tools Market

 

Radiation monitoring is a process of measuring radiation dose or any radionuclide contamination for the purpose of controlling the exposure to radiation or radioactive substances. The environmental protection agencies across the world carry out rigorous tests to ensure that environmental radiation is under internationally agreed safety limits. These tests also ensure that any change in environmental radiation level is notified so as to provide warnings and necessary protection advice. The radiation doses from artificial radioactivity are smaller and do not constitute any significant health risk than that from natural radiation. Read the rest of this entry »

Persistence Market Research (PMR) in its recent report titled, “Thailand Market Study on Water Pump: Industrial Segment to Witness Highest Growth by 2021”, projects that the Thailand water pump market is expected to grow at a healthy CAGR of 6.3% during the forecast period.

Interested in report: Please follow the below links to meet your requirements; 

Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/6197

In terms of revenue, the Thailand water pump market accounted for US$16.7 Million in 2014 and is projected to reach US$25.6 Million by 2021.Factors fuelling the market include low manufacturing costs, expansion of water supply network, massive urbanization and industrialization, increasing arable land and land under cereal production. Thailand is an agriculture-driven country. Growth in the agricultural sector, linked with increasing arable land and land under cereal production is leading to growing trend of micro irrigation in small farms, which is projected to increase deployment of centrifugal water pumps.

Similarly, the country is undergoing rapid economic growth and industrialisation and is also poised to emerge as a substantial market. It plays a crucial role as its one of the manufacturing hubs for water pumps. Deployment of monobloc pumps is increasing due to the growing trend of family farming, which is carried out on small agricultural plots and requires low HP centrifugal pump for micro irrigation. Pumps for domestic and agriculture application offer minimal product differentiation in terms of cost and quality. Similar buyer trends apply to both end-user segments.

On the basis of pump type, the submersible water pump segment is estimated to be the most dominant segment, with 63.5% of the overall Thailand water pump market share in 2015, followed by monobloc water pump segment with 36.5%share. Growth of the monobloc water pumps segment over the forecast period is expected to be driven by increasing demand for application in agro-industrial and food production purposes.

As of 2014, Thailand is among the world’s top ten countries in terms of water consumption for agro-industrial and food production. Central & Eastern Thailand region was the largest market in terms of revenue contribution, accounting for 30.2% of the overall Thailand water pump market in 2014.The Bangkok area is one of the most prosperous parts of Central & Eastern Thailand and is a dominant contributor to the national economy, with the infertile Northeast being the poorest in similar terms.Southern Thailand market is projected to lose 80 BPS during the forecast period. The region is part of a narrow peninsula, with a distinctive climate and terrain. Its economy is based on rice cultivation and rubber production. Mountainous terrain and absence of large rivers are conspicuous features of this region.

By end-use application, the agriculture segment is projected to continue its dominance throughout the forecast period. Agriculture application segment is expected to gain 40 BPS during the forecast period as a major portion of the country’s GDP is generated from agricultural activities. However, the industrial segment is forecasted to register the highest CAGR by 2021.Growth of the market in East Asia is mainly driven by increased adoption of water pumps in power plants, for development of new infrastructure, in heavy industry, municipal wastewater treatment plants, irrigation and drinking water facilities.

Key players in the Thailand water pump market includeGrundfos, KSB AG, Kirloskar Brothers Limited, Ebara Corporation. Global players like Grundfos, Sulzer Ltd, Flowserve Corporation focus on research and development initiatives to introduce innovative products to attain sustainable advantages over the competition. In addition, these players also focus on expanding their regional presence through mergers and acquisitions.

Request TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/6197

Water pump manufacturers in Thailand usually sell their products via distributors, who account for approximately 80% sales share as compared to 20% share via direct sales.Global and regional players in Thailand water pump market focus on entering into long-term tie-ups with engineering, procurement, and construction (EPC) companies and distributors. Chinese players have tie-ups with retailers to enhance customer reach.

Browse Full PDF: Thailand Water Pump Market

 

Persistence Market Research (PMR) delivers key insights on the Rheumatoid Arthritis Market in its latest report titled ‘Global Market Study on Rheumatoid Arthritis Diagnosis Tests: Increasing Efficiency of RA Test Kits to Drive Growth of the Market during the Forecast Period, 2015 – 2022’.

Interested in report: Please follow the below links to meet your requirements; 

Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/4788

The rheumatoid arthritis diagnosis tests market is expected to be valued at US$ 738.7 Mn by the end of 2022, expanding at a CAGR of 6.2% during the forecast period (2016–2022). Based on type of tests, the rheumatoid arthritis diagnosis tests market is segmented into serology test and treatment monitoring tests. Increasing incidence of autoimmune diseases, off-label prescription of NSAIDs and other pain management drugs are projected to increase demand for RA diagnosis. In addition, extensive focus on the high specificity and sensitivity of RA kits from kit manufacturers and favorable regulatory guidelines for rapid RA diagnostic kits are expected to fuel market growth. Commercialization of rapid diagnostic test, especially in anti-CCP test would provide key growth opportunities for RA test kits manufacturers.

However, higher costs of these test kits and limited sensitivity when performed as individual test are major restraining factors for this market. Revenue contribution of anti-CCP test segment has been estimated to be the highest, accounting for 31.0% of the total rheumatoid arthritis market share in 2015 and is expected to be one of the most lucrative segments over the forecast period. Limited sensitivity of other tests such as ANA antibody and RF test provide competitive advantage over anti-CCP test. However, availability of these tests at remote location of Asia Pacific region is a major challenge for the market.

Commercialization of cost-effective drugs to treat rheumatoid arthritis is expected promote growth of RA diagnosis tests market, as these medications require continuous monitoring of patients. Moreover, application of biomarker test for diagnosing rheumatoid arthritis could be the future for RA diagnosis, as various companies are focusing on development of biomarker test owing to limited efficacy of test kits currently available in the market.

On the basis of test type, the rheumatoid arthritis diagnosis tests market is segmented into serology test and RA treatment efficiency monitoring tests. Serology test segment is sub-segmented into Erythrocyte Sedimentation Rate (ESR) Tests, Rheumatoid Factor (RF) Tests, Anti-cyclic citrullinated peptide (anti-CCP) Tests, Antinuclear antibody (ANA) tests, uric acid tests and other tests. Anti-cyclic Citrullinated Peptide (anti-CCP) Tests sub-segment exhibits highest growth potential in overall serology test segment, and is projected to exhibit a CAGR of 7.4% during the forecast period; this is mainly attributed to its high sensitivity in early stage diagnosis of rheumatoid arthritis. RA treatment efficiency monitoring test segment is further sub-segmented into salicylate level count test, muscle enzyme tests (CPK, Aldolase) test and creatinine test. Salicylate level count test sub-segment has been estimated to hold highest share of ~46% in terms of revenue in 2015, owing to increase in off-label prescription of pain killer drugs such as Aspirin as RA treatment.

On the basis of geography, the rheumatoid arthritis diagnosis tests market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Europe and Asia Pacific regions have been estimated to collectively account for around 60% revenue share in 2015, owing to higher adoption of RA diagnosis test and increasing prevalence rate of autoimmune diseases. However, high RA prevalent region (North America) tend to become saturated in terms of revenue generation, owing to increasing awareness and healthcare spending for RA treatment and monitoring.

The report begins with an overview of the rheumatoid arthritis diagnosis tests market in terms of value, and a detailed analysis of key trends, drivers and restraints, and opportunities, which are the main factors impelling growth of the rheumatoid arthritis test market. Impact analysis of key growth drivers and restraints based on the weighted average of each of these factors in a model-based approach is included in the report. The report provides in-depth information on potential scope of high-end confirmatory testing kits to provide clients with crystal clear decision-making insights.

Request TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/4788

Key players operating in the rheumatoid arthritis diagnosis tests market include Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc. These companies are focusing on commercialization of cost-effective, highly-sensitive and rapid test kits. However, there is stiff competition from local manufacturers owing to low entry barriers and limited awareness about RA test efficiency among physicians.

Tag Cloud